Scott H Kaufmann

49PUBLICATIONS
322CO-AUTHORS
Learning analyticsHaematological tumoursMolecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|May 25, 2026
Factors affecting trainees' preferred timing of clinical clerkships during MD-PhD training.

|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

|Jan 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.

Julie R Duffield, Xiaonan Hou, Benjamin W Wilson

|Oct 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.

Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel

|Oct 16, 2025
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance.

Cordelia D McGehee, X Wei Meng, Xinyan Wu

|Jun 19, 2024
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer.

Esther P B Rodman, Michael J Emch, Xiaonan Hou

Pageof 9

Frequent Collaborators

8 joint publications

Haiming Dai

6 joint publications

Cristina Correia

6 joint publications

Elizabeth M Swisher

5 joint publications

Ann L Oberg